PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2018 at "BioMed Research International"
DOI: 10.1155/2018/2061268
Abstract: Introduction CD44 has been proposed as a prognostic marker and a stem cell marker but studies in patients with prostate cancer have yielded inconsistent results. Patients and Methods Patients submitted to radical prostatectomy between 2008… read more here.
Keywords: immunohistochemical evaluation; prostatectomies patients; patients adenocarcinoma; evaluation prostatectomies ... See more keywords